SCHEMBL17522147

SCHEMBL17522147

Ic1ccc(N2CCSCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.53
ALDH1A1 P00352 3/20 0.53
LGMN Q99538 2/20 0.50
LTA4H P09960 1/20 0.47
AKR1C3 P42330 2/20 0.44
THRB P10828 2/20 0.41
APP P05067 2/20 0.38
FAAH O00519 1/20 0.35
MGLL Q99685 1/20 0.35
DRD4 P21917 2/20 0.35
DRD3 P35462 1/20 0.35
HTT P42858 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
USP2 O75604 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14345952 0.83 AKR1C3 (0.57) MAPTALDH1A1LTA4HAKR1C3THRB
SCHEMBL12490848 0.79 ALDH1A1 (0.56) MAPTALDH1A1LGMNAKR1C3THRB
SCHEMBL625677 0.78 ALDH1A1 (0.54) MAPTALDH1A1LTA4HAKR1C3THRB
SCHEMBL18815076 0.78 LTA4H (0.52) MAPTALDH1A1LTA4HAKR1C3THRB
SCHEMBL3035197 0.77 LGMN (0.60) MAPTALDH1A1LGMNAKR1C3THRB
SCHEMBL16611429 0.77 MAPT (0.53) MAPTALDH1A1LGMNAKR1C3THRB
SCHEMBL9362762 0.77 MAPT (0.53) MAPTALDH1A1LGMNAKR1C3THRB
SCHEMBL3168651 0.77 ALDH1A1 (0.57) MAPTALDH1A1LGMNDRD4HTT
SCHEMBL8648308 0.77 ADRB1 (0.57) MAPTALDH1A1LGMNAKR1C3MEN1
SCHEMBL133561 0.76 ALDH1A1 (0.58) MAPTALDH1A1LTA4HAKR1C3THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017093544-A1 ALKYNYL PHOSPHINE GOLD COMPLEXES FOR TREATING BACTERIAL INFECTIONS AUSPHERIX LIMITED (GB) 2017-06-08 WO disclosed
WO-2016201370-A1 COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND KINASE INHIBITORS DANA-FARBER CANCER INSTITUTE, INC. (US) 2016-12-15 WO disclosed
WO-2016022970-A1 DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2016-02-11 WO disclosed